The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia

References

• OsbyUCorreiaNBrandtLEkbomAMortality and causes of death in schizophrenia in Stockholm county, SwedenSchizophr Res2000451–2212810978869
   PubMed Web of Science ®Google Scholar
• NewcomerJWMetabolic syndrome and mental illnessAm J Manag Care2007137 SupplS170S17718041878
   PubMed Web of Science ®Google Scholar
• McEvoyJPMeyerJMGoffDCPrevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES IIISchizophr Res2005801193216137860
   PubMed Web of Science ®Google Scholar
• CurkendallSMMoJGlasserDBCardiovascular disease in patients with schizophrenia in Saskatchewan, CanadaJ Clin Psychiatry200465571572015163261
   PubMed Web of Science ®Google Scholar
• HennekensCHHennekensARHollarDSchizophrenia and increased risks of cardiovascular diseaseAm Heart J200515061115112116338246
   PubMed Web of Science ®Google Scholar
• WannametheeSGShaperAGLennonLMetabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitusArch Intern Med2005165222644265016344423
   PubMedGoogle Scholar
• CohnTPrud’hommeDStreinerDCharacterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndromeCan J Psychiatry2004491175376015633853
   PubMed Web of Science ®Google Scholar
• RyanMCThakoreJHPhysical consequences of schizophrenia and its treatment: the metabolic syndromeLife Sci200271323925712034344
   PubMed Web of Science ®Google Scholar
• BobesJArangoCArandaPCardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS studySchizophr Res2007901–316217317123783
   PubMed Web of Science ®Google Scholar
• MelkerssonKClozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitroEur Neuropsychopharmacol200414211511915013026
   PubMed Web of Science ®Google Scholar
• SmithRCLindenmayerJPBarkNClozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patientsInt J Neuropsychopharmacol20058218319415737248
   PubMed Web of Science ®Google Scholar
• KovalMSRamesLJChristieSDiabetic ketoacidosis associated with clozapine treatmentAm J Psychiatry199415110152015218092346
   PubMed Web of Science ®Google Scholar
• MukherjeeSSchnurDBReddyRFamily history of type 2 diabetes in schizophrenic patientsLancet1989186364952563862
   PubMed Web of Science ®Google Scholar
• AdamsPFMaranoMACurrent estimates from the National Health Interview Survey, 1994Vital Health Stat 101995193Pt 1126015789506
   PubMedGoogle Scholar
• YangJLiuXLiuXAbnormality of glycometabolism related factors in non-psychotic offspring of schizophrenic patientsPsychiatry Res2012198218318622405633
   PubMed Web of Science ®Google Scholar
• SpelmanLMWalshPISharifiNImpaired glucose tolerance in first-episode drug-naive patients with schizophreniaDiabet Med200724548148517381506
   PubMed Web of Science ®Google Scholar
• GuestPCWangLHarrisLWIncreased levels of circulating insulin-related peptides in first-onset, antipsychotic naive schizophrenia patientsMol Psychiatry201015211811920098438
   PubMed Web of Science ®Google Scholar
• DasguptaASinghOPRoutJKInsulin resistance and metabolic profile in antipsychotic naive schizophrenia patientsProg Neuropsychopharmacol Biol Psychiatry20103471202120720600470
   PubMed Web of Science ®Google Scholar
• FreemanHResistance to insulin in mentally disturbed soldiersArch Neurol Psychiatry19465617478
   Google Scholar
• LiebzeitKAMarkowitzJSCaleyCFNew onset diabetes and atypical antipsychoticsEur Neuropsychopharmacol2001111253211226809
   PubMed Web of Science ®Google Scholar
• KollerESchneiderBBennettKClozapine-associated diabetesAm J Med2001111971672311747852
   PubMed Web of Science ®Google Scholar
• MelkerssonKIDahlMLHultingALGuidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolismPsychopharmacology (Berl)200417511615221198
   PubMed Web of Science ®Google Scholar
• LeslieDLRosenheckRAIncidence of newly diagnosed diabetes attributable to atypical antipsychotic medicationsAm J Psychiatry200416191709171115337666
   PubMed Web of Science ®Google Scholar
• MackinPBishopDWatkinsonHMetabolic disease and cardiovascular risk in people treated with antipsychotics in the communityBr J Psychiatry2007191232917602121
   PubMed Web of Science ®Google Scholar
• BirkenaesABBirkelandKIEnghJADyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditionsJ Clin Psychopharmacol200828213213718344722
   PubMed Web of Science ®Google Scholar
• PatelNCHariparsadMMatias-AktharMBody mass indexes and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychoticsJ Child Adolesc Psychopharmacol200717330331117630864
   PubMed Web of Science ®Google Scholar
• GaulinBDMarkowitzJSCaleyCFClozapine-associated elevation in serum triglyceridesAm J Psychiatry199915681270127210450273
   PubMed Web of Science ®Google Scholar
• Leitao-AzevedoCLGuimaraesLRde AbreuMGIncreased dyslipidemia in schizophrenic outpatients using new generation antipsychoticsRev Bras Psiquiatr200628430130417242810
   PubMed Web of Science ®Google Scholar
• HaffnerSMMiettinenHSternMPThe homeostasis model in the San Antonio Heart StudyDiabetes Care1997207108710929203442
   PubMed Web of Science ®Google Scholar
• FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721864995024337382
   PubMed Web of Science ®Google Scholar
• TirupatiSChuaLEObesity and metabolic syndrome in a psychiatric rehabilitation serviceAust N Z J Psychiatry200741760661017558623
   PubMed Web of Science ®Google Scholar
• WangGLiYFAssociation between lipoprotein(a) and coronary artery diseaseZhonghua Xin Xue Guan Bing Za Zhi201038761862021055285
   PubMedGoogle Scholar
• PatelJKBuckleyPFWoolsonSMetabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE studySchizophr Res20091111–391619398192
   PubMed Web of Science ®Google Scholar
• Perez-IglesiasRCrespo-FacorroBAmadoJAA 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidoneJ Clin Psychiatry200768111733174018052567
   PubMed Web of Science ®Google Scholar
• ZipurskyRBGuHGreenAICourse and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidolBr J Psychiatry200518753754316319406
   PubMed Web of Science ®Google Scholar
• RyanMMHuffakerSJWebsterMJApplication and optimization of microarray technologies for human postmortem brain studiesBiol Psychiatry200455432933614960284
   PubMed Web of Science ®Google Scholar
• YogaratnamJBiswasNVadivelRMetabolic complications of schizophrenia and antipsychotic medications-an updated reviewEast Asian Arch Psychiatry2013231212823535629
   PubMedGoogle Scholar
• ChaddaRKRamshankarPDebKSMetabolic syndrome in schizophrenia: differences between antipsychotic-naive and treated patientsJ Pharmacol Pharmacother20134317618623960422
   PubMedGoogle Scholar
• WuXHuangZWuRThe comparison of glycometabolism parameters and lipid profiles between drug-naive, first-episode schizophrenia patients and healthy controlsSchizophr Res2013150115716223998954
   PubMed Web of Science ®Google Scholar
• ReavenGMBanting lecture 1988. Role of insulin resistance in human diseaseDiabetes19883712159516073056758
   PubMed Web of Science ®Google Scholar
• HauptDWFahnestockPAFlavinKAAdiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patientsNeuropsychopharmacology200732122561256917375138
   PubMed Web of Science ®Google Scholar
• HendersonDCFanXSharmaBWaist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapineJ Psychiatr Pract200915425126119625881
   PubMed Web of Science ®Google Scholar
• OnatAAvciGSBarlanMMMeasures of abdominal obesity assessed for visceral adiposity and relation to coronary riskInt J Obes Relat Metab Disord20042881018102515197408
   PubMed Web of Science ®Google Scholar
• JiaWPLuJXXiangKSPrediction of abdominal visceral obesity from body mass index, waist circumference and waist–hip ratio in Chinese adults: receiver operating characteristic curves analysisBiomed Environ Sci200316320621114631825
   PubMed Web of Science ®Google Scholar
• ShenWPunyanityaMChenJWaist circumference correlates with metabolic syndrome indicators better than percentage fatObesity (Silver Spring)200614472773616741276
   PubMed Web of Science ®Google Scholar
• HoSCChenYMWooJLAssociation between simple anthropometric indices and cardiovascular risk factorsInt J Obes Relat Metab Disord200125111689169711753592
   PubMed Web of Science ®Google Scholar
• FarinHMAbbasiFReavenGMBody mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptakeMetabolism200554101323132816154431
   PubMed Web of Science ®Google Scholar
• FarinHMAbbasiFReavenGMBody mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adultsAm J Clin Nutr2006831475116400048
   PubMed Web of Science ®Google Scholar
• FarinHMAbbasiFReavenGMComparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individualsAm J Cardiol20069881053105617027570
   PubMed Web of Science ®Google Scholar
• DaltonMCameronAJZimmetPZWaist circumference, waist– hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adultsJ Intern Med2003254655556314641796
   PubMed Web of Science ®Google Scholar